dc.creatorVerre, Vladimiro
dc.creatorMilesi, Dario
dc.creatorPetelski, Natalia
dc.date2014-09-05T22:58:38Z
dc.date2014-09-05T22:58:38Z
dc.date2013
dc.date.accessioned2018-04-19T21:05:20Z
dc.date.available2018-04-19T21:05:20Z
dc.identifierJournal of Technology Management & Innovation 8(3): 2013, p. 127-138
dc.identifiere0718-2724
dc.identifier1090-2747-1-PB.pdf
dc.identifierhttp://repositorio.uahurtado.cl/handle/11242/2186
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1371013
dc.descriptionThe article presents a study on the use of secrecy in Argentine biopharmaceutical firms that innovate through public-private cooperation. When innovation is achieved by cooperating with public and external sources of knowledge, the company is exposed to higher risks that critical knowledge leaks out to potential competitors, undermining the effectiveness of secrecy. To investigate this issue, study cases have been conducted on firms whose innovation projects are carried out by cooperating with public R&D institutions. The results suggest that the specific features of cooperation determine different possibilities for firms to face those risks, adapt its strategy of appropriation and protect the generated knowledge
dc.languagespa
dc.publisherUniversidad Alberto Hurtado. Facultad de Economía y Negocios
dc.rightsAttribution 3.0 Unported
dc.rightshttp://creativecommons.org/licenses/by/3.0/
dc.subjectInnovación
dc.subjectCooperación en I+D
dc.subjectSecreto industrial
dc.subjectApropiación
dc.subjectBiofarmacéutico
dc.titleSecreto Industrial y Cooperación Público-privada en I+D en el Sector Biofarmacéutico Argentino
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución